Discover 3,507 paid clinical trials in Santa Monica, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 3,507
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
for
Obesity or Overweight, Type 2 Diabetes Mellitus
Location: Long Beach CA, Irvine CA, Montclair CA, Lake Forest CA,
Sponsor: Hoffmann-La Roche
Sex: All
Age: 18+
Code: NCT07351058
Phase 3, Recruiting
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
for
Idiopathic Short Stature
Location: Los Angeles CA, Torrance CA, California City CA,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 3 - 11
Code: NCT06382155
Phase 2, Recruiting
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
for
Hepatocellular Carcinoma (HCC)
Location: Glendale CA, Olympia WA, Tacoma WA, Houston TX,
Sponsor: Shanghai Henlius Biotech
Sex: All
Age: 18 - 65
Code: NCT07176650
Phase 1, Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
for
Carcinoma, Non-Small-Cell Lung
Location: Long Beach CA, Fullerton CA, Denver CO, Laredo TX,
Sponsor: Mirati Therapeutics Inc.
Sex: All
Age: 18+
Code: NCT06875310
Phase 3, Recruiting
A Phase 3 Trial to Compare IV BCV Versus IV CDV for Treatment of Adenovirus Infection After Allo-HCT
for
Adenovirus Infections
Location: Duarte CA, San Diego CA, Palo Alto CA, Sacramento CA,
Sponsor: SymBio Pharmaceuticals
Sex: All
Age: 0+
Code: NCT07387367
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Immune Tolerance Induction After Liver Transplantation
Location: Los Angeles CA, Orange CA, San Francisco CA, Aurora CO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 30
Code: NCT04851119
Phase 1, Phase 2, Recruiting
A Study of CD19 Targeted CAR T Cell Therapy in Pediatric Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia (B ALL) and Aggressive Mature B-cell Non-Hodgkin Lymphoma (B NHL)
for
Relapsed or Refractory B Cell Acute Lymphoblastic Leukemia,
Location: Los Angeles CA, Palo Alto CA, Salt Lake City UT,
Sponsor: Autolus Limited
Sex: All
Age: 0 - 18
Code: NCT06173518
Phase 1, Recruiting
Fecal Microbiome Transplant to Remodel Intestinal Microbiota for Patients With Relapsed or Refractory Lymphoma With Exposure to High-Risk Antibiotics Who Are Receiving Chimeric Antigen Receptor T Cells
for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18+
Code: NCT07042438
Phase 2, Recruiting
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
for
B-cell Acute Lymphoblastic Leukemia, Obesity
Location: Los Angeles CA, Orange CA, San Francisco CA,
Sponsor: Etan Orgel
Sex: All
Age: 7 - 25
Code: NCT05082519
Phase 2, Recruiting
DISCOVERY of Risk Factors for Type 2 Diabetes in Youth
for
Diabetes Mellitus Type 2, Childhood-Onset
Location: Los Angeles CA, Phoenix AZ, Shiprock NM, Aurora CO,
Sponsor: George Washington University
Sex: All
Age: 8 - 15
Code: NCT06525259
Recruiting
Pediatric Positive End Expiratory Pressure (PEEP) Titration Using Electrical Impedence Tomography (EIT)
for
Pediatric Acute Respiratory Distress Syndrome
Location: Los Angeles CA
Sponsor: Children's Hospital Los Angeles
Sex: All
Age: 0 - 18
Code: NCT06684119
Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Duarte CA, Orange CA, Palo Alto CA, Salt Lake City UT,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma